FDA-approved BRIXADI is a prescription medicine for opioid addiction, also called opioid use disorder (OUD). Please see Prescribing Information, including Boxed Warning, and Medication Guide.

Mar 22, 2026 · Brixadi (buprenorphine) is a weekly or monthly injection used to treat moderate to severe opioid use disorder (OUD). Includes side effects, warnings, dosage, and interactions.

The U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder (OUD)

Official HCP site for BRIXADI, the only FDA-approved injectable buprenorphine for opioid use disorder (OUD) that offers weekly and monthly doses. Please see Full Prescribing Information, including …

Dec 16, 2024 · Find patient medical information for Brixadi (buprenorphine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Buprenorphine is available under the brand names Cizdol, Brixadi (approved in the US by FDA for addiction treatment in 2023), Suboxone (with naloxone), Subutex (typically used for opioid use …

Dec 9, 2024 · Brixadi is a prescription drug used to treat opioid use disorder. Learn about the common, mild, and serious side effects it can cause and how to manage them.

Oct 30, 2024 · Brixadi is an extended-release form of buprenorphine (an FDA-approved medication used to treat OUD that can be prescribed in physician offices) that continuously releases and …

Jul 31, 2023 · Brixadi (buprenorphine) is an injection given under the skin by a healthcare professional for moderate to severe opioid use disorder. It's typically given along with counseling, as well as social …

The most common side effects of BRIXADI include: injection site pain, headache, constipation, nausea, injection site redness, injection site itching, trouble sleeping (insomnia), and urinary tract infection. …